May 10
|
bluebird bio Inc (BLUE) Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Focus ...
|
May 10
|
bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well
|
May 9
|
bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
|
May 6
|
bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events
|
May 6
|
bluebird bio Announces Completion of First Cell Collection for LYFGENIAâ„¢ Gene Therapy
|
Apr 26
|
bluebird bio Announces Receipt of Expected Notice from Nasdaq
|
Apr 15
|
Is Bluebird Bio Stock a Buy?
|
Apr 13
|
Better Buy: Bluebird Bio Vs. Novavax
|
Apr 11
|
Is This Beaten-Down Stock a Good Acquisition Target?
|
Apr 11
|
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Apr 2
|
bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript
|
Mar 29
|
Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst
|
Mar 26
|
bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance
|
Mar 25
|
bluebird bio to Host Fourth Quarter and 2023 Annual Results Conference Call
|
Mar 18
|
Why Bluebird Bio Stock Flew Higher Than the Market Today
|
Mar 18
|
bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital
|
Mar 13
|
Is Bluebird Bio Stock a Buy Now?
|
Mar 11
|
bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy
|
Mar 5
|
Why Bluebird Bio Stock Dived Into the Red on Tuesday
|
Jan 27
|
If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today
|